Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation.
Stamouli M, Gkirkas K, Tsirigotis P.
Immunotherapy. 2016;8(1):57-68. doi: 10.2217/imt.15.100. Epub 2015 Dec 7.
PMID:26641929
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience.
Uchibori Y, Kurosawa S, Najima Y, Haraguchi K, Sadato D, Hirama C, Sadaga Y, Kondo K, Kato C, Sakai S, Kambara Y, Ouchi F, Shimabukuro M, Jinguji A, Shingai N, Toya T, Shimizu H, Kobayashi T, Harada H, Harada Y, Okuyama Y, Doki N.
Front Immunol. 2025 Jan 29;16:1521895. doi: 10.3389/fimmu.2025.1521895. eCollection 2025.
PMID:39944683
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant.
Bednarski JJ, Zimmerman C, Berrien-Elliott MM, Foltz JA, Becker-Hapak M, Neal CC, Foster M, Schappe T, McClain E, Pence PP, Desai S, Kersting-Schadek S, Wong P, Russler-Germain DA, Fisk B, Lie WR, Eisele J, Hyde S, Bhatt ST, Griffith OL, Griffith M, Petti AA, Cashen AF, Fehniger TA.
Blood. 2022 Mar 17;139(11):1670-1683. doi: 10.1182/blood.2021013972.
PMID:34871371
Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review.
Durer S, Durer C, Shafqat M, Comba IY, Malik S, Faridi W, Aslam S, Ijaz A, Tariq MJ, Fraz MA, Usman M, Khan AY, McBride A, Anwer F.
Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review.
Yanagisawa R, Nakazawa Y, Sakashita K, Saito S, Tanaka M, Shiohara M, Shimodaira S, Koike K.
Int J Hematol. 2016 Jan;103(1):107-11. doi: 10.1007/s12185-015-1902-1. Epub 2015 Nov 19.